Skip to content
Wenlo
Sign in
← Markets

Guardant Health, Inc.

Guardant Health, Inc. (GH) — Form 8-K: Current report

8-KGHFiled Nov 3, 2026, 8:19 AM ET· Period Nov 2, 2026

AI-generated summary

Guardant Health, Inc. announced that its Board of Directors approved performance-based restricted stock unit awards for its co-founders and Co-Chief Executive Officers, Helmy Eltoukhy and AmirAli Talasaz. Each Co-CEO received a target grant of 465,413 PSUs. The awards vest based on total shareholder return relative to the S&P 500 Index over three-year and five-year performance periods.

Key facts

  • Item 5.02 · Executive or director change or pay arrangement
  • Item 9.01 · Financial statements and exhibits

More GH filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.